Biomarkers and IA sketches a new future for multiple sclerosis, explained by two expert neurologists
Multiple sclerosis has stopped from a rare disease in Spain.
55.000 diagnosed people (most women), this pathology
neurological course
Chronically, it has developed significantly in its clinical approach due to early diagnostics, therapeutic innovation and the use of new technology.However, the challenges continue.They express it
Officials at Getafe University Hospital's Multiple Sclerosis Division, Professor at the University of Madrid, Yolanda Adro,
Luzain Costa-Prozaard, a neurologist at Ramon University Hospital and the University of Kajal and a researcher at the Ramon Institute and Cage to MS to investigate Sanity (IYCIS), Nun Consonto dialogue in the medical act for Novart.
Yolanda Aradro, responsible for many universities of sclerosis, neurologist, university of neurologist, university of madrid, and university of neurologist
Aladro pointed out that the classic clinical forms of the disease are re -examined: "I think it is convenient to know that they are
Phenotypes, these clinical forms (repetitive normal, progressive primary and progressive secondary)
They change and in the future, we are very far away and we speak
Multiple sclerosis repeated when there are outbreaks, whether or not developing below (subliminal or gentle), and progressive multiple sclerosis, or not outbreaks.We can see them as soon as possible.The clinic.So in the future we can talk about other forms of many sclerosis.
Find out and stop making the progress is one of the most important challenges of two professionals."It is very difficult to identify and measure it.
This challenge: Expliscually clear biomers.And on this course we know those patients will continue to increase their way.On the other hand, in connection with growth, there are some problems.I think you agree with me, so we love it.We have measured with clockwise."Are you going here?" Or "How much did you walk on the street?"We need additional therapists.The digital devices entered, which will allow us to balance the patient's development, both in March and understanding of damage.Even with digital equipment you can do. "
Yolanda Aladro: "The patient has changed. The patient knows more.
Costa Frosard adds: "In terms of research,
We Also Have To GROWNATION BIOMARKERS AND ENTIFICIAL INTELLGENCEE IMPROVE AND EVEN HOMANIZE, IT IS POSSIBLE TO MONTOR THE PATIENTS WHOVE HAVE BEEN AD TO PATIENTS AND HAVE.Support-The Support of the Patients And the Support of the Support of the Support of The Patients and to the thea work of the worm of the worm of the worm of the work of theThe Work and to the Work of the Work of the Work of the Work of the Work of the Work of the Work of the Work of the Work and the work and work of work and work.To continue to move their family. "
Aladro strengthens this idea:
"This is true that this is difficult to fall in the doctor, our responsibility to try to heal the best illness
In many cases, we need psychological support because we talk about major decisions between 28 and 30 years, and these tasks must be treated by public and private institutions, but it doesn't matter
Lucienna Costa Frussaard: "Today we have a good technology, a bloody nerve, blood-fleefned nerve, and have a good technology"
Achievements in technological innovation and biomarkers change paradigm."Artificial intelligence is a reality," says Costa Bristcard. "We have a program that uses a program that uses patients and measures the speed on your mobile phone. We have received information about progress.
The patient does not have to be specifically.
The whole tech development allows us to return to the cost: Listen, listen, go, and give advice. "
Alaadro agrees with the engineer to provide examples of his work. "We will work with the University of Polytechnic and Group in the United States that have developed the device as socks covered by patients. This technology is advanced, but patients are expected to have very quick results.
And of course of the development of pharmacology. "
In terms of patient associations, Aladro says: "This has changed.
We have moved from a paternalistic attitude four or five decades ago in a model where the patient has more information and can make decisions.But in order for the patient to decide on their illness, he or she needs quality information.If you have no information if you have partial information, your decision is limited.Marriage: You get married with that medicine.Therefore, you have to agree on you.I don't show the treatment you don't follow.The patient's decision is necessary and must be widespread. "
He added to Costa Phazar, "Every patient is an understanding of something. Some people don't know. Some unpleasant patients.
We did not relate patients: "There are 14 molecules, select".We choose 2 or 3 dispatched for your profile, and in the person we have to decide together. "
At the end of the conversation, the two experts overlap in a message that conveys the recently diagnosed patient.Aldero concludes this as follows: "The first message is to calm down. If you hear" MS ", you are illuminated.
It is a long disease, which is under most of most of most often.Could not, but yes
We clearly change your diagnosis.Today, very few patients need wheelchairs or depend on high levels.This is a disease that you can live. ""
Coast-Frostard admitted: "When they arrived at the disease, they were afraid. Our death is not complete with a pregnant disease.
But we change dramatically not only for prognosis, but the patient can do.May have a family to be studying, working.And, above all things will not go in this way.It will be with us, because the whole team who works in the clinical attention, basic research, applied to research and social support. "
Aladero concludes a future message: “I also give you hope.
I think the future is even better. We have improved a lot, but what comes is even better.I really believe.
Medical writing dialogues on many sclerosis.
Information about medical writing contains statements, data and statements from official institutions and health workers.How all questions regarding your health specialization.